US Stock MarketDetailed Quotes

COEP Coeptis Therapeutics

Watchlist
  • 0.190
  • +0.005+2.87%
Trading Dec 12 09:37 ET
7.81MMarket Cap-0.68P/E (TTM)

Coeptis Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
0
0
0
0
0
0
0
0
0
Gross profit
0
0
0
0
0
0
0
0
0
0
Operating expense
-72.89%2.14M
-23.25%2.83M
-55.31%2.92M
-37.15%21.49M
4.55%3.37M
43.34%7.9M
-62.20%3.68M
-58.39%6.54M
142.17%34.2M
5.89%3.22M
Selling and administrative expenses
-58.11%1.08M
-26.58%2.18M
-69.30%1.9M
-56.63%14.82M
-3.63%3.1M
-53.05%2.58M
-69.55%2.97M
-60.72%6.17M
142.02%34.18M
5.89%3.22M
-Selling and marketing expense
--0
1,566.67%5K
----
52.56%12.71K
-100.07%-1
334.14%12.41K
-92.60%300
----
185.50%8.33K
--1.42K
-General and administrative expense
-57.91%1.08M
-26.74%2.17M
-69.30%1.9M
-56.65%14.81M
-3.58%3.1M
-53.25%2.57M
-69.54%2.97M
-60.72%6.17M
142.01%34.17M
5.84%3.22M
Research and development costs
-84.00%811.78K
-14.53%398.82K
573.78%777.07K
31,825.33%6.67M
--1.01M
24,187.54%5.07M
--466.63K
--115.33K
--20.89K
--0
Depreciation amortization depletion
0.00%250K
0.00%250K
0.00%250K
----
----
--250K
--250K
--250K
----
----
-Depreciation and amortization
0.00%250K
0.00%250K
0.00%250K
----
----
--250K
--250K
--250K
----
----
Operating profit
72.89%-2.14M
23.25%-2.83M
55.31%-2.92M
37.15%-21.49M
-4.55%-3.37M
-43.34%-7.9M
62.20%-3.68M
58.39%-6.54M
-143.46%-34.2M
-5.89%-3.22M
Net non-operating interest income expense
-157.20%-50.93K
-54.93%-66.06K
-538.21%-200.51K
50.70%-107.69K
67.33%-13.83K
64.91%-19.8K
33.20%-42.64K
43.72%-31.42K
-16.71%-218.41K
-153.43%-42.34K
Non-operating interest expense
157.20%50.93K
54.93%66.06K
538.21%200.51K
-50.70%107.69K
-67.33%13.83K
-64.91%19.8K
-33.20%42.64K
-43.72%31.42K
16.71%218.41K
153.43%42.34K
Other net income (expense)
-76.84%363.8K
-126.89%-141.19K
108.76%121.5K
110.52%332.27K
-217.91%-375.79K
2,063.16%1.57M
5,141.09%525K
59.29%-1.39M
-503.15%-3.16M
162.50%318.7K
Gain on sale of security
-78.28%349.5K
-128.43%-149.25K
102.51%34.88K
--567.75K
---178.88K
--1.61M
--525K
---1.39M
----
----
Special income (charges)
---37.26K
----
----
--0
--0
--0
----
----
-169,577.10%-3.39M
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
--3.39M
--0
-Write off
--37.26K
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
233.57%51.56K
--8.06K
247,400.00%86.63K
-200.76%-235.48K
-161.79%-196.91K
51.75%-38.6K
----
--35
-70.26%233.7K
162.50%318.7K
Income before tax
71.20%-1.83M
5.22%-3.04M
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
71.20%-1.83M
5.22%-3.04M
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
Net income continuous Operations
71.20%-1.83M
5.22%-3.04M
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
Minority interest income
0
0
Net income attributable to the parent company
71.20%-1.83M
5.22%-3.04M
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
71.20%-1.83M
5.22%-3.04M
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
Basic earnings per share
79.17%-0.05
46.67%-0.08
80.00%-0.08
68.44%-0.83
53.46%-0.07
17.08%-0.24
68.72%-0.15
57.37%-0.4
-299.72%-2.63
-8.27%-0.1504
Diluted earnings per share
79.17%-0.05
46.67%-0.08
80.00%-0.08
68.44%-0.83
53.46%-0.07
17.08%-0.24
68.72%-0.15
57.37%-0.4
-299.72%-2.63
-8.27%-0.1504
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0000000000
Gross profit 0000000000
Operating expense -72.89%2.14M-23.25%2.83M-55.31%2.92M-37.15%21.49M4.55%3.37M43.34%7.9M-62.20%3.68M-58.39%6.54M142.17%34.2M5.89%3.22M
Selling and administrative expenses -58.11%1.08M-26.58%2.18M-69.30%1.9M-56.63%14.82M-3.63%3.1M-53.05%2.58M-69.55%2.97M-60.72%6.17M142.02%34.18M5.89%3.22M
-Selling and marketing expense --01,566.67%5K----52.56%12.71K-100.07%-1334.14%12.41K-92.60%300----185.50%8.33K--1.42K
-General and administrative expense -57.91%1.08M-26.74%2.17M-69.30%1.9M-56.65%14.81M-3.58%3.1M-53.25%2.57M-69.54%2.97M-60.72%6.17M142.01%34.17M5.84%3.22M
Research and development costs -84.00%811.78K-14.53%398.82K573.78%777.07K31,825.33%6.67M--1.01M24,187.54%5.07M--466.63K--115.33K--20.89K--0
Depreciation amortization depletion 0.00%250K0.00%250K0.00%250K----------250K--250K--250K--------
-Depreciation and amortization 0.00%250K0.00%250K0.00%250K----------250K--250K--250K--------
Operating profit 72.89%-2.14M23.25%-2.83M55.31%-2.92M37.15%-21.49M-4.55%-3.37M-43.34%-7.9M62.20%-3.68M58.39%-6.54M-143.46%-34.2M-5.89%-3.22M
Net non-operating interest income expense -157.20%-50.93K-54.93%-66.06K-538.21%-200.51K50.70%-107.69K67.33%-13.83K64.91%-19.8K33.20%-42.64K43.72%-31.42K-16.71%-218.41K-153.43%-42.34K
Non-operating interest expense 157.20%50.93K54.93%66.06K538.21%200.51K-50.70%107.69K-67.33%13.83K-64.91%19.8K-33.20%42.64K-43.72%31.42K16.71%218.41K153.43%42.34K
Other net income (expense) -76.84%363.8K-126.89%-141.19K108.76%121.5K110.52%332.27K-217.91%-375.79K2,063.16%1.57M5,141.09%525K59.29%-1.39M-503.15%-3.16M162.50%318.7K
Gain on sale of security -78.28%349.5K-128.43%-149.25K102.51%34.88K--567.75K---178.88K--1.61M--525K---1.39M--------
Special income (charges) ---37.26K----------0--0--0---------169,577.10%-3.39M--0
-Less:Other special charges ----------------------------------3.39M--0
-Write off --37.26K------------------0----------------
Other non- operating income (expenses) 233.57%51.56K--8.06K247,400.00%86.63K-200.76%-235.48K-161.79%-196.91K51.75%-38.6K------35-70.26%233.7K162.50%318.7K
Income before tax 71.20%-1.83M5.22%-3.04M62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M
Income tax 0000000000
Net income 71.20%-1.83M5.22%-3.04M62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M
Net income continuous Operations 71.20%-1.83M5.22%-3.04M62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M
Minority interest income 00
Net income attributable to the parent company 71.20%-1.83M5.22%-3.04M62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 71.20%-1.83M5.22%-3.04M62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M
Basic earnings per share 79.17%-0.0546.67%-0.0880.00%-0.0868.44%-0.8353.46%-0.0717.08%-0.2468.72%-0.1557.37%-0.4-299.72%-2.63-8.27%-0.1504
Diluted earnings per share 79.17%-0.0546.67%-0.0880.00%-0.0868.44%-0.8353.46%-0.0717.08%-0.2468.72%-0.1557.37%-0.4-299.72%-2.63-8.27%-0.1504
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data